Therapy Areas: Hereditary Disorders
9 June 2020 - The United States Food and Drug Administration (FDA) has granted United States-based Insmed Incorporated (Nasdaq:INSM) breakthrough therapy designation for its brensocatib (formerly know...
29 May 2020 - Preclinical-stage company OrPro Therapeutics said on Thursday that it is expanding its technology platform for treatment of acute and chronic airway diseases, including cystic fibrosis (...
26 May 2020 - - Australian medical technology company 4DMedical has received clearance from the US Food and Drug Administration to market its XV Technology, the company said.

The XV Techn...
26 May 2020 - Australian medical company 4DMedical reported on Monday the receipt of clearance from the US Food & Drug Administration to market its XV Technology that rapidly and automatically ana...
6 May 2020 - - Montreal-based biopharmaceutical company Laurent Pharmaceuticals Inc has obtained the approval from Health Canada to initiate RESOLUTION, a Phase 2 randomized placebo-controlled trial t...
6 May 2020 - AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company based in the US, has received acceptance from the United States Federal Trade Commission (FTC) for the proposed cons...